aluates Reports

$ 0.0

Automative

Global Juvenile Idiopathic Arthritis Diagnostic Market Research Report 2026

Published Date: 2026-01-30

Report Code: QYRE-Auto-19E18521

Global Juvenile Idiopathic Arthritis Diagnostic Market Research Report 2024

BUY CHAPTERS

Global Juvenile Idiopathic Arthritis Diagnostic Market Research Report 2026

Code: QYRE-Auto-19E18521

Report

2026-01-30

Pages:120

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Abbott

Danaher

Siemens Healthineers

Thermo Fisher Scientific

Sysmex

Biomerieux

Siemens AG

Philips

Canon Medical

Hitachi

United-imaging

Juvenile Idiopathic Arthritis Diagnostic Market Size

The global Juvenile Idiopathic Arthritis Diagnostic market was valued at US$ 6643 million in 2025 and is anticipated to reach US$ 8708 million by 2032, at a CAGR of 4.0% from 2026 to 2032.

Juvenile Idiopathic Arthritis Diagnostic Market

Juvenile Idiopathic Arthritis (JIA) is a type of arthritis that occurs in children under the age of 16. It is characterized by persistent joint inflammation, stiffness, and pain that lasts for at least six weeks, without any known cause. JIA is an autoimmune disorder, meaning the body's immune system mistakenly attacks its own tissues, primarily affecting joints but potentially also other organs. Diagnosing JIA involves clinical evaluation, imaging (like X-rays or MRIs), and laboratory tests (such as blood tests for inflammation markers and specific antibodies) to rule out other conditions and confirm the diagnosis.

The North American market for Juvenile Idiopathic Arthritis Diagnostic is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Juvenile Idiopathic Arthritis Diagnostic is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Juvenile Idiopathic Arthritis Diagnostic in Hospitals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Juvenile Idiopathic Arthritis Diagnostic include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, BioMerieux, Siemens, Philips, GE, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Juvenile Idiopathic Arthritis Diagnostic market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Juvenile Idiopathic Arthritis Diagnostic. The Juvenile Idiopathic Arthritis Diagnostic market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Juvenile Idiopathic Arthritis Diagnostic market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Juvenile Idiopathic Arthritis Diagnostic manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Juvenile Idiopathic Arthritis Diagnostic Market Report

Report Metric	Details
Report Name	Juvenile Idiopathic Arthritis Diagnostic Market
Accounted market size in 2025	US$ 6643 million
Forecasted market size in 2032	US$ 8708 million
CAGR	4.0%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Blood Tests Imaging Scans
Segment by Application	Hospitals Laboratories Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, BioMerieux, Siemens, Philips, GE, Canon Medical, Hitachi, United Imaging
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Juvenile Idiopathic Arthritis Diagnostic companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Juvenile Idiopathic Arthritis Diagnostic Market growing?

Ans: The Juvenile Idiopathic Arthritis Diagnostic Market witnessing a CAGR of 4.0% during the forecast period 2026-2032.

What is the Juvenile Idiopathic Arthritis Diagnostic Market size in 2032?

Ans: The Juvenile Idiopathic Arthritis Diagnostic Market size in 2032 will be US$ 8708 million.

Who are the main players in the Juvenile Idiopathic Arthritis Diagnostic Market report?

Ans: The main players in the Juvenile Idiopathic Arthritis Diagnostic Market are Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, BioMerieux, Siemens, Philips, GE, Canon Medical, Hitachi, United Imaging

What are the Application segmentation covered in the Juvenile Idiopathic Arthritis Diagnostic Market report?

Ans: The Applications covered in the Juvenile Idiopathic Arthritis Diagnostic Market report are Hospitals, Laboratories, Other

What are the Type segmentation covered in the Juvenile Idiopathic Arthritis Diagnostic Market report?

Ans: The Types covered in the Juvenile Idiopathic Arthritis Diagnostic Market report are Blood Tests, Imaging Scans

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Blood Tests

1.2.3 Imaging Scans

1.3 Market by Application

1.3.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals

1.3.3 Laboratories

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Perspective (2021–2032)

2.2 Global Juvenile Idiopathic Arthritis Diagnostic Growth Trends by Region

2.2.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Juvenile Idiopathic Arthritis Diagnostic Historic Market Size by Region (2021–2026)

2.2.3 Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Region (2027–2032)

2.3 Juvenile Idiopathic Arthritis Diagnostic Market Dynamics

2.3.1 Juvenile Idiopathic Arthritis Diagnostic Industry Trends

2.3.2 Juvenile Idiopathic Arthritis Diagnostic Market Drivers

2.3.3 Juvenile Idiopathic Arthritis Diagnostic Market Challenges

2.3.4 Juvenile Idiopathic Arthritis Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Juvenile Idiopathic Arthritis Diagnostic Players by Revenue

3.1.1 Global Top Juvenile Idiopathic Arthritis Diagnostic Players by Revenue (2021–2026)

3.1.2 Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Players (2021–2026)

3.2 Global Top Juvenile Idiopathic Arthritis Diagnostic Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Juvenile Idiopathic Arthritis Diagnostic Revenue

3.4 Global Juvenile Idiopathic Arthritis Diagnostic Market Concentration Ratio

3.4.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Juvenile Idiopathic Arthritis Diagnostic Revenue in 2025

3.5 Global Key Players of Juvenile Idiopathic Arthritis Diagnostic Head Offices and Areas Served

3.6 Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Products and Applications

3.7 Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Juvenile Idiopathic Arthritis Diagnostic Breakdown Data by Type

4.1 Global Juvenile Idiopathic Arthritis Diagnostic Historic Market Size by Type (2021–2026)

4.2 Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Type (2027–2032)

5 Juvenile Idiopathic Arthritis Diagnostic Breakdown Data by Application

5.1 Global Juvenile Idiopathic Arthritis Diagnostic Historic Market Size by Application (2021–2026)

5.2 Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)

6.2 North America Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021–2026)

6.4 North America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)

7.2 Europe Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021–2026)

7.4 Europe Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)

8.2 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (2021–2026)

8.4 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)

9.2 Latin America Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021–2026)

9.4 Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)

10.2 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021–2026)

10.4 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Juvenile Idiopathic Arthritis Diagnostic Introduction

11.1.4 Roche Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

11.1.5 Roche Recent Development

11.2 Abbott

11.2.1 Abbott Company Details

11.2.2 Abbott Business Overview

11.2.3 Abbott Juvenile Idiopathic Arthritis Diagnostic Introduction

11.2.4 Abbott Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

11.2.5 Abbott Recent Development

11.3 Danaher

11.3.1 Danaher Company Details

11.3.2 Danaher Business Overview

11.3.3 Danaher Juvenile Idiopathic Arthritis Diagnostic Introduction

11.3.4 Danaher Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

11.3.5 Danaher Recent Development

11.4 Siemens Healthineers

11.4.1 Siemens Healthineers Company Details

11.4.2 Siemens Healthineers Business Overview

11.4.3 Siemens Healthineers Juvenile Idiopathic Arthritis Diagnostic Introduction

11.4.4 Siemens Healthineers Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

11.4.5 Siemens Healthineers Recent Development

11.5 Thermo Fisher Scientific

11.5.1 Thermo Fisher Scientific Company Details

11.5.2 Thermo Fisher Scientific Business Overview

11.5.3 Thermo Fisher Scientific Juvenile Idiopathic Arthritis Diagnostic Introduction

11.5.4 Thermo Fisher Scientific Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

11.5.5 Thermo Fisher Scientific Recent Development

11.6 Sysmex

11.6.1 Sysmex Company Details

11.6.2 Sysmex Business Overview

11.6.3 Sysmex Juvenile Idiopathic Arthritis Diagnostic Introduction

11.6.4 Sysmex Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

11.6.5 Sysmex Recent Development

11.7 BioMerieux

11.7.1 BioMerieux Company Details

11.7.2 BioMerieux Business Overview

11.7.3 BioMerieux Juvenile Idiopathic Arthritis Diagnostic Introduction

11.7.4 BioMerieux Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

11.7.5 BioMerieux Recent Development

11.8 Siemens

11.8.1 Siemens Company Details

11.8.2 Siemens Business Overview

11.8.3 Siemens Juvenile Idiopathic Arthritis Diagnostic Introduction

11.8.4 Siemens Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

11.8.5 Siemens Recent Development

11.9 Philips

11.9.1 Philips Company Details

11.9.2 Philips Business Overview

11.9.3 Philips Juvenile Idiopathic Arthritis Diagnostic Introduction

11.9.4 Philips Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

11.9.5 Philips Recent Development

11.10 GE

11.10.1 GE Company Details

11.10.2 GE Business Overview

11.10.3 GE Juvenile Idiopathic Arthritis Diagnostic Introduction

11.10.4 GE Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

11.10.5 GE Recent Development

11.11 Canon Medical

11.11.1 Canon Medical Company Details

11.11.2 Canon Medical Business Overview

11.11.3 Canon Medical Juvenile Idiopathic Arthritis Diagnostic Introduction

11.11.4 Canon Medical Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

11.11.5 Canon Medical Recent Development

11.12 Hitachi

11.12.1 Hitachi Company Details

11.12.2 Hitachi Business Overview

11.12.3 Hitachi Juvenile Idiopathic Arthritis Diagnostic Introduction

11.12.4 Hitachi Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

11.12.5 Hitachi Recent Development

11.13 United Imaging

11.13.1 United Imaging Company Details

11.13.2 United Imaging Business Overview

11.13.3 United Imaging Juvenile Idiopathic Arthritis Diagnostic Introduction

11.13.4 United Imaging Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

11.13.5 United Imaging Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Abbott

Danaher

Siemens Healthineers

Thermo Fisher Scientific

Sysmex

Biomerieux

Siemens AG

Philips

Canon Medical

Hitachi

United-imaging

List of Tables

Table 1. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Blood Tests

Table 3. Key Players of Imaging Scans

Table 4. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (US$ Million), 2021–2026

Table 7. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Region (2021–2026)

Table 8. Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Region (2027–2032)

Table 10. Juvenile Idiopathic Arthritis Diagnostic Market Trends

Table 11. Juvenile Idiopathic Arthritis Diagnostic Market Drivers

Table 12. Juvenile Idiopathic Arthritis Diagnostic Market Challenges

Table 13. Juvenile Idiopathic Arthritis Diagnostic Market Restraints

Table 14. Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Players (US$ Million), 2021–2026

Table 15. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Players (2021–2026)

Table 16. Global Top Juvenile Idiopathic Arthritis Diagnostic Players by Tier (Tier 1, Tier 2, and Tier 3), based on Juvenile Idiopathic Arthritis Diagnostic Revenue, 2025

Table 17. Ranking of Global Top Juvenile Idiopathic Arthritis Diagnostic Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Juvenile Idiopathic Arthritis Diagnostic Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Headquarters and Area Served

Table 20. Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Products and Applications

Table 21. Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Type (US$ Million), 2021–2026

Table 24. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Type (2021–2026)

Table 25. Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Type (2027–2032)

Table 27. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Application (US$ Million), 2021–2026

Table 28. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Application (2021–2026)

Table 29. Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Application (2027–2032)

Table 31. North America Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2021–2026

Table 33. North America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2027–2032

Table 46. Roche Company Details

Table 47. Roche Business Overview

Table 48. Roche Juvenile Idiopathic Arthritis Diagnostic Product

Table 49. Roche Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026

Table 50. Roche Recent Development

Table 51. Abbott Company Details

Table 52. Abbott Business Overview

Table 53. Abbott Juvenile Idiopathic Arthritis Diagnostic Product

Table 54. Abbott Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026

Table 55. Abbott Recent Development

Table 56. Danaher Company Details

Table 57. Danaher Business Overview

Table 58. Danaher Juvenile Idiopathic Arthritis Diagnostic Product

Table 59. Danaher Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026

Table 60. Danaher Recent Development

Table 61. Siemens Healthineers Company Details

Table 62. Siemens Healthineers Business Overview

Table 63. Siemens Healthineers Juvenile Idiopathic Arthritis Diagnostic Product

Table 64. Siemens Healthineers Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026

Table 65. Siemens Healthineers Recent Development

Table 66. Thermo Fisher Scientific Company Details

Table 67. Thermo Fisher Scientific Business Overview

Table 68. Thermo Fisher Scientific Juvenile Idiopathic Arthritis Diagnostic Product

Table 69. Thermo Fisher Scientific Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026

Table 70. Thermo Fisher Scientific Recent Development

Table 71. Sysmex Company Details

Table 72. Sysmex Business Overview

Table 73. Sysmex Juvenile Idiopathic Arthritis Diagnostic Product

Table 74. Sysmex Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026

Table 75. Sysmex Recent Development

Table 76. BioMerieux Company Details

Table 77. BioMerieux Business Overview

Table 78. BioMerieux Juvenile Idiopathic Arthritis Diagnostic Product

Table 79. BioMerieux Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026

Table 80. BioMerieux Recent Development

Table 81. Siemens Company Details

Table 82. Siemens Business Overview

Table 83. Siemens Juvenile Idiopathic Arthritis Diagnostic Product

Table 84. Siemens Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026

Table 85. Siemens Recent Development

Table 86. Philips Company Details

Table 87. Philips Business Overview

Table 88. Philips Juvenile Idiopathic Arthritis Diagnostic Product

Table 89. Philips Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026

Table 90. Philips Recent Development

Table 91. GE Company Details

Table 92. GE Business Overview

Table 93. GE Juvenile Idiopathic Arthritis Diagnostic Product

Table 94. GE Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026

Table 95. GE Recent Development

Table 96. Canon Medical Company Details

Table 97. Canon Medical Business Overview

Table 98. Canon Medical Juvenile Idiopathic Arthritis Diagnostic Product

Table 99. Canon Medical Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026

Table 100. Canon Medical Recent Development

Table 101. Hitachi Company Details

Table 102. Hitachi Business Overview

Table 103. Hitachi Juvenile Idiopathic Arthritis Diagnostic Product

Table 104. Hitachi Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026

Table 105. Hitachi Recent Development

Table 106. United Imaging Company Details

Table 107. United Imaging Business Overview

Table 108. United Imaging Juvenile Idiopathic Arthritis Diagnostic Product

Table 109. United Imaging Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026

Table 110. United Imaging Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Juvenile Idiopathic Arthritis Diagnostic Picture

Figure 2. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Type: 2025 vs 2032

Figure 4. Blood Tests Features

Figure 5. Imaging Scans Features

Figure 6. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Application: 2025 vs 2032

Figure 8. Hospitals Case Studies

Figure 9. Laboratories Case Studies

Figure 10. Other Case Studies

Figure 11. Juvenile Idiopathic Arthritis Diagnostic Report Years Considered

Figure 12. Global Juvenile Idiopathic Arthritis Diagnostic Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Region: 2025 vs 2032

Figure 15. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Players in 2025

Figure 16. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Juvenile Idiopathic Arthritis Diagnostic Revenue in 2025

Figure 18. North America Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Juvenile Idiopathic Arthritis Diagnostic Market Share by Country (2021–2032)

Figure 20. United States Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Juvenile Idiopathic Arthritis Diagnostic Market Share by Country (2021–2032)

Figure 24. Germany Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Share by Region (2021–2032)

Figure 32. China Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Share by Country (2021–2032)

Figure 40. Mexico Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Share by Country (2021–2032)

Figure 44. Israel Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Roche Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

Figure 48. Abbott Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

Figure 49. Danaher Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

Figure 50. Siemens Healthineers Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

Figure 52. Sysmex Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

Figure 53. BioMerieux Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

Figure 54. Siemens Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

Figure 55. Philips Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

Figure 56. GE Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

Figure 57. Canon Medical Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

Figure 58. Hitachi Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

Figure 59. United Imaging Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Juvenile Idiopathic Arthritis Treatment Market Insights Forecast to 2030

Global Rheumatoid Arthritis Medicine Market Research Report 2025

Global Juvenile Health Insurance Market Research Report 2024

Global Rheumatoid Arthritis Testing Market Research Report 2025

Global Osteoarthritis Treatment Market Research Report 2024

Global Rheumatoid Arthritis RA Medications Market Research Report 2025

Global Tocilizumab Drugs Market Research Report 2024

Global Juvenile Insurance Market Research Report 2024

Diagnosis of Autoimmune Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatoid Arthritis Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Rheumatic Drugs Market Research Report 2024

Global Sacroiliitis Treatment Market Research Report 2024

Global Arthritis Monoclonal Antibodies Market Research Report 2024

Global Psoriatic Arthritis PsA Treatment Market Research Report 2024

Global Tocilizumab Market Research Report 2024

Pediatric Imaging Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Systemic Autoinflammatory Diseases Drug Market Research Report 2024

Global Mononucleosis Diagnostic Market Insights Forecast to 2030

AL Amyloidosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions